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Abstract
The development of the mammary gland is spatially regulated by the interaction of the mammary epithelium with the extracellular
matrix (ECM). Cells receive cues from the ECM through a family of adhesion receptors called integrins, consisting of- and-chain
dimers. Integrins assist cells in sensing their appropriate developmental context in response to both hormones and growth factors.
Here we argue that cell adhesion to the ECM plays a key role in specific developmental checkpoints, particularly in alveolar survival,
morphogenesis and function. Specific ablation of 1-integrins in the luminal epithelium of the mammary gland shows that this
sub-type of receptors is required for proliferation, accurate morphological organisation, as well as milk secretion. Downstream,
small Rho GTPases mediate cellular polarisation and differentiation. Current challenges in studying the integration of signals in
checkpoints of mammary gland development are discussed.
© 2007 Published by Elsevier Ltd.
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1. The temporal–spatial nature of mammary
gland development
The hormonal control of mammary gland develop-
ment has been studied over several decades (Ceriani,
1974; Vonderhaar, 1988; Neville, McFadden, & Forsyth,
2002; Hennighausen & Robinson, 2005). The spatial
aspect, which refers to how mammary epithelial cells
(MECs) interact with their surroundings, has been exam-
ined only in recent years (Streuli, 2003). Current genetic
analysis has demonstrated that the extracellular matrix
(ECM) has a major role in dictating how MECs behave in
vivo (Faraldo, Deugnier, Lukashev, Thiery, & Glukhova,
1998; Li et al., 2005; Naylor et al., 2005; Guo et al.,
2006).
In the juvenile mammal, the mammary gland con-
sists of primitive ducts, with limited side branching.
Upon stimulus by ovarian hormones during puberty,
these ducts elongate and branch further into the fat pad
surrounding the gland. With pregnancy, the ends of the
branches in the ductal system become mature acinar
structures, also known as terminal ductal-lobular units
(TDLUs) or alveoli (Oakes, Hilton, & Ormandy, 2006).
Stromal and myoepithelial cells encompass each duct
and alveolus, and provide essential cues for MEC sur-
vival, proliferation and terminal differentiation leading
to milk secretion during lactation. The fully differenti-
ated alveoli are made of a single layer of luminal MECs
encompassing a single hollow lumen, and surrounded by
both myoepithelial cells and basement membrane (BM),
which is a specialised type of ECM. The myoepithelial
cells, and the stroma beyond them, regulate mammary
development through the localised secretion of a vari-
ety of growth factors (Sternlicht, 2006). Myoepithelial
cells have further functions of spatially restricting epithe-
lial cells to form ducts during puberty, mechanically
expelling the secreted milk from alveoli, and acting as
tumour suppressors (Lakhani & Bissell, 2005).
The BM is established by stromal–epithelial interac-
tions leading to secretion of specific ECM components,
and assembly of the 100 nm thick matrix at the basal
surface of the epithelium (Kedinger, Lefebvre, Duluc,
Freund, & Simon-Assmann, 1998; Streuli, 2006). MECs
adhere via several types of ECM receptors, one class of
which is composed of hetero-dimeric - and -chain
integrins (Taddei et al., 2003; Naylor & Streuli, 2006).
At least 24 integrin dimers are known, showing a great
diversity of ligands (Giancotti & Tarone, 2003; Taddei
et al., 2003; Jin & Varner, 2004). An emerging concept
is that one of the functions for integrins is to moni-
tor the ECM environment, thereby equipping cells with
context-dependent checkpoints for signaling. Thus, inte-ochemistry & Cell Biology 39 (2007) 715–726
grins only permit growth factor/cytokine responses in
cells that are in an appropriate location, providing an
important device to maintain normal tissue homeostasis
(ffrench-Constant & Colognato, 2004; Guo & Giancotti,
2004; Streuli, 2006).
This review will concentrate on the known effects of
ECM on MEC behaviour, particularly focussing on the
BM, and the specific integrin signalling events under-
lying them. We will discuss how integrin-mediated
adhesion serves as a checkpoint for different aspects
of MEC function through integration with other signals
received during mammary gland development.
2. Adhesion signalling in the mammary gland
The ECM consists of multiple components, depend-
ing on the stroma and epithelium within the specific
tissue. The mammary BM contains collagen IV (Col
IV) and Laminin I (LM-1, renamed recently as LM-
111 (Aumailley et al., 2005)), as well as LM-5, 10
and 11 (LM-3A32, -511 and -521, respec-
tively). These are cross-linked by nidogen-1 and -2
(also known as entactins) to form a gel-like structure
to which MECs adhere (Prince et al., 2002). The mam-
mary stoma secretes a separate set of ECM components
such as fibronectin (FN) and tenascins (TNs) (Sakakura,
Ishihara, & Yatani, 1991; Schedin, Mitrenga, McDaniel,
& Kaeck, 2004; Scherberich et al., 2005).
While some of the studies to dissect ECM function
have used purified ECM components, others rely on
BM isolated from the Engelbreth–Holm–Swarm tumour
(known commercially as Matrigel), which is thought
to mimic effectively the mammary BM (Kleinman et
al., 1986). There are wide variety of adhesion recep-
tors for BM proteins in the mammary gland, including
non-integrin receptors such as dystroglycan, syndecan,
galactosyl transferase (Streuli, 2003). However, their
specific roles are still not fully clear. Integrin dimers con-
taining the 1 subunit are required for proper mammary
gland development (Klinowska et al., 1999; Li et al.,
2005; Naylor et al., 2005). Nonetheless, the -subunits
involved in different aspects of mammary function have
not yet been defined (Schatzmann, Marlow, & Streuli,
2003; Taddei et al., 2003). Although differentiation sig-
nals in vivo require spatial cues from a LM-1 integrin
axis, it is not yet clear which -integrins deliver the
key intracellular responses. When genes were deleted
independently, two important binding partners of inte-
grin 1 and 4, the 3 and 6 integrin chains, were
dispensable in mammary gland development (Klinowska
et al., 2001). This indicates some degree of redundancy
in MEC integrin function.
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Integrins bind ECM proteins when in an extended
ctive conformation, and simultaneously promote the
ormation of multi-protein adhesion complexes at the
lasma membrane (Geiger, Bershadsky, Pankov, &
amada, 2001; Humphries et al., 2003). Adhesion
omplexes are both focal centres for assembling the
ytoskeleton and signalling platforms for controlling
ell behaviour (DeMali, Wennerberg, & Burridge, 2003;
iranti & Brugge, 2002). They function through recruit-
ent of a variety of structural proteins (e.g., talin,
inculin), adaptor proteins (e.g., paxillin, p130Cas,
arvin), and enzymes (e.g., integrin-linked kinase (ILK),
yk, focal adhesion kinase (FAK), Src, small GTPases)
Zamir & Geiger, 2001; Cukierman, Pankov, & Yamada,
002; Brakebusch & Fassler, 2003). The proximal adhe-
ion complex components are well defined in cell types
uch as fibroblasts and endothelial cells (Gaus, Le
ay, Balasubramanian, & Schwartz, 2006; Pirone et al.,
006), as well epithelial cells in two-dimensional (2D)
ultures (Liu et al., 2006). Focal adhesion-like struc-
ures formed by MECs on BM (our unpublished data)
r in vivo may resemble those in their usage of com-
onents such as ILK, Syk, and FAK. Nonetheless, the
ignal generated by integrins through the focal adhe-
ion depends on the physical ECM properties (Wozniak,
esai, Solski, Der, & Keely, 2003) and may reflect
hanges in the composition of the signalling complex
tself.
ILK binds to -chains of various integrin dimers and
ts activation leads to many important events downstream
f integrin signalling (Hannigan, Troussard, & Dedhar,
005; Legate, Montanez, Kudlacek, & Fassler, 2006;
chatzmann et al., 2003). ILK is especially important
n inducing cytoskeletal reorganization, a critical event
n cell polarization and morphogenesis. Moreover ILK
ppears to have a key role in the differentiation response
f mammary epithelium (R Marlow and CH Streuli,
npublished data).
Another kinase interacting directly with the inte-
rin -chains is Syk (Dejmek et al., 2005). This kinase
articipates in activation of hematopoietic cells, inte-
rin signalling and MEC transformation (de Virgilio,
iosses, & Shattil, 2004; Dejmek et al., 2005; Katz et
l., 2005). Similarly to integrin signalling in hematopoi-
tic cells, Syk may induce actin polymerisation via the
av guanine exchange factor family (Miranti, Leng,
aschberger, Brugge, & Shattil, 1998). It may also be
nvolved in cross-talk with EGFR in MECs (Ruschel &
llrich, 2004).
The interaction of cells with ECM leads to the for-
ation of focal adhesions, an event that involves FAK.
his enzyme is linked to activated integrins through thechemistry & Cell Biology 39 (2007) 715–726 717
proteins talin and paxillin (Schatzmann et al., 2003).
In MECs, the complex that FAK forms downstream of
integrin activation may be separate from that which is
formed by ILK or Syk (Miranti et al., 1998). Activation
of FAK is intimately related to activation of Src tyro-
sine kinases. Src kinases are activated by growth factor
receptors and may act as a link between them and inte-
grin signalling (Brunton, MacPherson, & Frame, 2004).
Moreover, Src is involved with MEC development and
proliferation through its effects on estrogen receptor-
 (ER) and the adaptor protein p130Cas (Cabodi et
al., 2006; Kim, Laing, & Muller, 2005). In fibroblasts,
endothelia and other cell types, FAK activation leads
to proliferative signals through the MAPK cascade. An
adaptor protein linking FAK to this cascade, Shc, binds
only to specific integrin dimers, such as 11, 51,
v3 and 64 (Mainiero et al., 1995; Wary, Mainiero,
Isakoff, Marcantonio, & Giancotti, 1996).
A pressing question is to decipher the molecular
details of how integrins control fate decisions of mam-
mary epithelium, and elucidating the role of specific
adhesion complex components will be implicit in this
analysis.
3. Survival and apoptosis
Perhaps the most general role ascribed to integrin-
mediated adhesion is cell survival. In virtually all
adherent cells, including MECs, cell detachment from
the ECM leads to a type of programmed cell death
(or apoptosis) called anoikis (Frisch & Francis, 1994;
Gilmore, 2005).
The mechanism for anoikis in MEC has been
explained in part, and involves a direct signalling path-
way linking integrins to the intrinsic control centre
for apoptosis, the mitochondria. The initiating events
are poorly understood, but within 15 min of disen-
gaging integrins and the ensuing cell detachment,
the pro-apoptotic proteins Bax and Bid translocate
to the mitochondrial membrane (Gilmore, Metcalfe,
Romer, & Streuli, 2000; Valentijn & Gilmore, 2004;
Valentijn, Metcalfe, Kott, Streuli, & Gilmore, 2003;
Wang, Valentijn, Gilmore, & Streuli, 2003). As a result,
the mitochondrial membrane potential depolarises and
cytochrome c is released to the cytoplasm. Cytochrome
c, together with Apaf-1, activates the cysteine protease
family of caspases, which cleaves a wide range of protein
targets ultimately resulting in cell death (Jin & El-Deiry,
2005).
Studies in mammary cell lines have indicated that
FAK over-expression can prevent anoikis (Gilmore et al.,
2000). Conversely, MEC genetically lacking 1 integrin
al of Bi718 E. Katz, C.H. Streuli / The International Journ
show increased apoptosis in tissue culture, concomi-
tant with reduced FAK phosphorylation (Li et al., 2005;
Naylor et al., 2005). FAK is linked to Rac activation
downstream of 1 integrin in fibroblasts (Hirsch et al.,
2002) and may function similarly in MECs as well.
Fig. 1. (A) MECs require a basement membrane (BM) checkpoint for surviva
undergoing anoikis. A pro-survival signal from activated integrin dimers med
The integrin signal integrates with one from the insulin receptor (InsR) to p
as the cell adheres to the BM. (B) The proliferation checkpoint comprises sig
MECs (left) express integrin 51 and this enables a p38-mediated signal fr
(right) express different 1-integrin dimers. As a result, they are receptive to i
receptor, while TGF signalling is inactive. (C) MEC-BM interaction provides
adhesion signals for both polarisation and milk secretion into the lumen. Ra
signals from both glucocorticoids and integrins 31 and 61 to maintain
the phosphatase SHP-2 may be blocked to enable prolactin-mediated STAT5ochemistry & Cell Biology 39 (2007) 715–726
Moreover, FAK may regulate Bax translocation to mito-
chondria through a pathway involving PI3K, protein
kinase B (PKB/Akt), and the serine–threonine kinase,
Pak1 (P. Wang, Q. Pu, C.H. Streuli, unpublished data)
(Fig. 1A).
l. Adhesion of MECs through integrins to the BM prevents cells from
iated by FAK blocks Bax and BID translocation to the mitochondria.
romote long-term survival. These events prevent cell death, as long
nals from growth factors, hormones and integrins. In the duct, some
om activated TGF to inhibit their proliferation. Neighbouring cells
ntegrated proliferative signals from the EGFR family and the estrogen
a checkpoint for terminal differentiation. MECs within alveoli require
c GTPase is central for both events. Together with JNK, it integrates
cell polarisation. In another branch of signalling downstream of Rac,
phosphorylation and production of milk proteins.
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The ECM per se is not sufficient for sustained MEC
urvival, but requires particular matrix ligands. The BM
rotein LM-1 suppresses anoikis much more efficiently
han stromal ECM such as Col I (Pullan et al., 1996),
hough it is not yet clear whether ECM can trigger sur-
ival responses, when presented as individual proteins
r if assembly into higher-order matrices is required.
lthough the survival stimulus partly results from inter-
ction between LM-1 and its receptor, the64 integrin,
dditional signals from insulin or insulin-like growth
actor (IGF) are also required (Fig. 1A) (Farrelly, Lee,
liver, Dive, & Streuli, 1999). The signalling effects
f insulin/IGF, leading to phosphorylation of the adap-
or, insulin receptor substrate 1 (IRS1), and activation
f the PI3K pathway, are generally much more substan-
ial and persistent when cells are cultured on purified
M than on Col I (Lee & Streuli, 1999). This indicates
hat ECM adhesion receptors are integrated intracellu-
arly with those for the soluble survival factors (such as
nsulin and IGF). The integration providing this matrix-
pecific checkpoint for survival is still in need of further
larification at the molecular level, but may involve
ombinatorial downstream signals, or physical associ-
tion of the receptors either directly or within lipid
afts, as occurs in other cell types (Decker & ffrench-
onstant, 2004). The ECM-integrin survival axis likely
orks together with signals from cadherin-mediated
ell–cell interactions in the mammary gland (Boussadia,
utsch, Hierholzer, Delmas, & Kemler, 2002), though
his hypothesis received little current attention.
Accumulation of milk in alveoli at the end of lactation
eads to a tissue-remodelling process known as involu-
ion (Green & Streuli, 2004; Hennighausen & Robinson,
005; Watson, 2006). Although anoikis contributes to
nvolution, it is unclear whether anoikis in MECs is
ell autonomous. In endothelial cells, upregulation of
ell death receptors such as Fas ligand and/or downreg-
lation of cell receptor signalling suppressors such as
-FLIP accounts indirectly to anoikis (Aoudjit & Vuori,
001). This extrinsic apoptotic pathway requires a subset
f caspases that are largely independent of mitochon-
rial membrane potential depolarization (Jin & El-Deiry,
005). FasL-activated caspases do not play a role in MEC
noikis in vitro (Wang et al., 2003). Nonetheless, apop-
osis during involution may include both anoikis and cell
eath receptors (Clarkson et al., 2006).
The contribution of other cell intrinsic pro-apoptotic
roteins to anoikis of MECs is still largely unknown. In
uman MECs, p53 expression was sufficient to sensitise
noikis in response to inhibition of 31-ECM contact
Seewaldt et al., 2001). Evidence in vivo indicates that
uring involution 1integrin is inactivated (Prince et al.,chemistry & Cell Biology 39 (2007) 715–726 719
2002) or that there is down-regulation of both1 integrin
and FAK expression (McMahon, Farr, Singh, Wheeler,
& Davis, 2004). Hence, loss of integrin signalling (i.e.,
anoikis) may contribute directly to involution. A com-
plementary view suggests that involution occurs as a
result of changes in the composition of the mammary
BM ((McDaniel et al., 2006) and see below). In this case,
changes in specific integrin dimer cross-linking may be
sufficient to induce anoikis. For example, such change
may involve a switch from 1-containing integrins to
alternate dimers, as a result of1 de-activation (Beauvais
& Rapraeger, 2003).
In summary, adhesion to the ECM is an absolute
requirement for cell survival. However, since survival
is ECM-specific (i.e., it depends on a BM), we view
cell–BM interactions as a positive checkpoint to sup-
press apoptosis, ensuring that mammary epithelial cells
are normally only maintained within ducts and alveoli.
This is one of the mechanisms guaranteeing that devel-
opment occurs normally, leading to the formation of
intricate epithelial structures that underlie the function of
the tissue. A corollary is that if this apoptosis checkpoint
becomes activated autonomously, MEC may acquire the
potential to survive within inappropriate ECM locations,
such as within stroma or lymph nodes; this is a prereq-
uisite for the more subversive aspects of breast cancer,
when tumours become malignant.
4. Proliferative hormonal responses
The development of the mammary gland is tightly
regulated by a variety of hormones, both metabolic and
reproductive (Neville et al., 2002). During pregnancy,
estrogen and progesterone are critical for MEC prolif-
eration. Estrogen contributes to ductal elongation and
stimulation of prolactin release from the pituitary gland
(Brisken, 2002). The formation of alveolar structures and
side branching is largely dependent on progesterone and
prolactin (Oakes et al., 2006). The combined effects of
prolactin and ECM in terminal differentiation are dis-
cussed in a separate section below.
An important study has compared the ability of MECs
from virgin and pregnant mice to respond to estrogen
and/or progestin, when adhered to Col IV. Both hor-
mones were capable of stimulating proliferation in the
virgin MECs, but not cells derived from pregnant mice
(Xie & Haslam, 1997). Neither cell type proliferates in
response to BM adhesion or hormonal stimulation alone
(Xie & Haslam, 1997; Haslam & Woodward, 2003).
Taken together, this evidence suggests that the ECM
assists the MECs to respond in accordance with their
developmental stage. Contradicting studies exist regard-
al of Bi720 E. Katz, C.H. Streuli / The International Journ
ing the regulation of progesterone or estrogen receptor
expression by adhesion to BM. One study found them
unchanged even in combination of BM adhesion with
growth factors, with or without estrogen (Woodward,
Xie, Fendrick, & Haslam, 2000). Another group reported
that ER expression is induced by adhesion to purified
BM or its major components, LM-1 and Col IV (Novaro,
Roskelley, & Bissell, 2003). Furthermore, antibodies to
integrin chains 2 and 1 blocked this regulatory effect.
Since both studies have used primary MECs, such dis-
crepancies may result from differing culture conditions
and await resolution.
MEC proliferation requires integrin-mediated ECM
adhesion because genetic deletion of 1 integrin leads to
cell cycle arrest and defective mammary gland develop-
ment in vivo (Li et al., 2005). Crucially, neither adhesion
nor hormones alone are sufficient for MEC proliferation,
but their integrated signals are required. Therefore, in
this checkpoint, cells proliferate in response to hormonal
stimulation only if the adhesion context is permissive.
5. Growth factor signalling
A variety of growth factors contribute to the devel-
opment of the mammary gland, mostly secreted by the
surrounding stroma and myoepithelial cells (Sternlicht,
2006). The receptors for most growth factors are of the
receptor tyrosine kinase class, which is known to have
significant cross-talk with integrin signalling (Brunton
et al., 2004; Guo & Giancotti, 2004). Most available evi-
dence for such cross-talk concentrates on four growth
factor families: EGF, IGF, TGF and HGF.
The receptors for EGF ligands such as amphiregulin
(EGFR) and neuregulin (ErbB4) are required for proper
alveolar development (Yang et al., 1995; Sternlicht,
2006). Using a normal MEC cell line cultured on puri-
fied BM, alveolar development was reproduced using
ErbB2 stimulation and shown to be dependent on the
MEK/ERK pathway (Niemann et al., 1998). Primary
MECs from both virgin and pregnant mice proliferate
in response to EGF on any ECM component examined
(Xie & Haslam, 1997). More differential effects of ECM
components on EGFR signaling are not entirely clear.
Col IV, LM and FN (but not Col I) adhesion reduce EGF
binding to its receptors, EGFR and ErbB2 (Woodward
et al., 2000). Both EGFR protein expression and phos-
phorylation are higher when MECs adhere to Col I than
to purified BM (Lee & Streuli, 1999). In contrast, ErbB2
phosphorylation is more extensive on BM than on Col I.
As a result, ERK phosphorylation downstream of EGFR
stimulation is weaker upon BM adhesion. Interestingly,
blocking integrin 1 in malignant MECs cultured onochemistry & Cell Biology 39 (2007) 715–726
purified BM reverses EGFR phosphorylation and sub-
sequent MAPK activation (Wang et al., 1998). This
differential in ECM responsiveness to EGF signalling is
reflected by radically different growth characteristics of
mammary cells cultured in 2D environments on stromal
ECM with growth in three-dimensional (3D) matrices
on purified BM (Muthuswamy, Li, Lelievre, Bissell, &
Brugge, 2001).
IGF-I is locally induced within the mammary stroma
by systemic growth hormone and is capable of mimick-
ing the effects of insulin in supporting, together with the
ECM, survival of MECs (Farrelly et al., 1999; Kleinberg,
Feldman, & Ruan, 2000). Adhesion to several ECM
components (Col I, Col IV, LM and FN) enhances the
combined proliferative effect of EGF and IGF-I. EGF
stimulates expression of inhibitory IGF-binding proteins
in MECs and this effect is suppressed by adhesion to
ECM (Woodward et al., 2000).
TGF has a well-documented role in inhibition of
MEC proliferation and modulating epithelial plastic-
ity (Bhowmick, Zent, Ghiassi, McDonnell, & Moses,
2001; Ewan et al., 2005). Ectopic expression of 5-
integrin leads to an increase in both type II TGF receptor
expression and autocrine TGF secretion in transformed
mammary cells, suggesting a link between integrin and
TGF (Wang et al., 1999). In other cell lines, normal
and transformed, a SMAD-independent TGF activa-
tion of p38 MAPK depends on integrin 1 (Bhowmick
et al., 2001). Nonetheless, MECs adhering to purified
BM do not undergo apoptosis in response to TGF1
(Pullan et al., 1996). The emerging evidence of interplay
between estrogen-induced proliferation and its restraint
by autocrine TGF (Ewan et al., 2005) leads to interest-
ing questions regarding the role of the ECM in this cell
fate checkpoint. It is possible that ECM adhesion enables
TGF to inhibit hormone-driven MEC proliferation, but
not to induce apoptosis in vivo (Fig. 1B).
HGF and its receptor c-Met are involved in branch-
ing of mammary ducts in a PI3K-dependent manner
(Niemann et al., 1998). HGF induces branching of
MECs, in vitro, on both Col I and Fibrin gels (Alford,
Baeckstrom, Geyp, Pitha, & Taylor-Papadimitriou,
1998). MECs cultured on Col I and treated with a combi-
nation of HGF and progestin show behaviour remarkably
similar to that observed in mammary alveoli (Haslam
& Woodward, 2003). Conversely, HGF antibodies are
sufficient to reverse mammary development induced by
estrogen and progestin treatment in vivo. Induction of
branching by HGF can be reversed in vitro by inhibition
of the proper integrin  chain (21 for Col I and 31
for Fibrin). De-activation of 1 integrin is also sufficient
to block HGF-induced branching on Col I (Klinowska
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t al., 1999). Evidence in vivo suggests a unique role of
21 integrin in the branching process (Chen, Diacovo,
renache, Santoro, & Zutter, 2002), although the inte-
ration of signals from HGF and/or hormones was not
haracterized at this level.
Growth factor signalling determines whether MEC
roliferate, undergo apoptosis, or form branched
tructures. However, only cell interactions with the
ppropriate ECM context, mediated by integrins, allow
he proper developmental decision. Thus, although
rowth factors have a wide variety of effects on cells,
CM adhesion permits a much more specific set of out-
omes than might have been predicted from studies using
D culture on plastic alone.
These collective studies therefore indicate that adhe-
ion provides a key checkpoint to determine the
roliferative fate of MEC. Subversion of this check-
oint has disastrous consequences, sometimes leading
o cancer. The expression of an integrin dimer, the 64
aminin receptor, is altered in breast cancer, contribut-
ng to poor patient prognosis (Tagliabue et al., 1998).
ntegrin 64 co-localises and associates with ErbB2
n breast cancer cells (but probably not in normal cells),
esulting in a gain of function that enhances proliferation
nd migration (Falcioni et al., 1997). Recent studies have
ndicated that suppression of 4-integrin in the context
f breast cancer, through shRNA approaches or deletion
f its signalling domain, has a profound effect on tumori-
enesis by reducing ErbB2 signalling thereby preventing
roliferation and survival (Lipscomb et al., 2005; Bon et
l., 2006; Guo et al., 2006; Yoon, Shin, & Lipscomb,
006). Thus, understanding how adhesion checkpoints
ormally work and how they can become altered in can-
er has significant implications for future therapeutic
venues.
. Acinar morphology
Acinar structures in vivo (or alveoli) are made of a
ual layer of cells: an internal layer of luminal epithelial
ells encompassed in a mesh-like layer of myoepithe-
ial cells (Adriance, Inman, Petersen, & Bissell, 2005).
oth primary MECs and mammary cell lines form acinar
tructures in three-dimensional culture on purified BM.
he cells polarise and form a central hollow lumen into
hich milk will ultimately be secreted. Acinar structures
f primary MECs form mostly as a result of cell aggre-
ation and subsequent cell polarisation (Barcellos-Hoff,
ggeler, Ram, & Bissell, 1989; Aggeler et al., 1991).
n contrast, mammary cell lines develop acinar struc-
ures on BM from a proliferating single cell (Debnath &
rugge, 2005). In vivo, alveoli form as a result of prolif-chemistry & Cell Biology 39 (2007) 715–726 721
eration, aggregation, other changes in cell fate (such as
reduction in cell death), or a combination of these factors.
The cellular events that are particular to MECs
forming alveoli are only partially understood. In other
epithelial systems, cellular polarity and lumen formation
on purified BM are closely linked (Straight et al., 2004).
Polarity is highly dependent on actin polymerisation
down-stream of integrins, which is normally mediated
by small GTPases. A candidate effector in the mammary
epithelium is ILK, which has a critical role in cell spread-
ing (Filipenko, Attwell, Roskelley, & Dedhar, 2005).
Actin polymerisation is achieved by ILK activation of
-parvin and its subsequent interaction with -PIX, a
guanine nucleotide exchange factor for both Rac and
Cdc42. The contribution of these small GTPases to aci-
nar morphology (and milk synthesis) has recently been
described (Akhtar & Streuli, 2006). Rho itself was pro-
posed to be a sensor of ECM rigidity and therefore to
determine the morphological fate of MECs (Paszek &
Weaver, 2004; Wozniak et al., 2003). On flexible ECM,
Rho activity is low and tubules resembling ducts are
formed. On a rigid ECM, Rho activity is high and MECs
proliferate. Although such studies have been undertaken
in mammary cell lines, this may be an attractive expla-
nation for the way the ECM dictates whether ductal
or alveolar structures will be formed, if ECM rigidity
indeed changes during mammary development in vivo.
Systemic glucocorticoids also contribute to acinar
architecture (Fig. 1C). Without hydrocortisone, several
stages in acinar morphology do not occur, including
cell polarisation and tight junction formation. A sin-
gle signalling pathway was implicated downstream of
glucocorticoids, the MEKK4/JNK pathway, induced by
BRCA1/GADD4 (Murtagh et al., 2004). In these stud-
ies, inhibition of the JNK pathway was sufficient to
disrupt proper integrin 4 expression and lumen for-
mation, two events that are likely to be related to one
another.
Polarised acinar structures are key components of
the mammary gland, allowing it to deliver milk to
infants. We suggest that integrin signalling through small
GTPases provide an essential polarisation check point.
Without these integrators of adhesion function, actin
polymerisaton is absent and acinar structures do not form
properly. The JNK pathway is also required for this pro-
cess, thus only coordinated signals from the ECM and
glucocorticoids result in lumen formation.7. Terminal differentiation
Prolactin drives both alveolar proliferation and differ-
entiation during pregnancy, and the subsequent secretion
al of Bi722 E. Katz, C.H. Streuli / The International Journ
of milk into the alveolar lumen (Oakes et al., 2006). How-
ever, an appropriate ECM is also required for proper
mammary differentiation and milk secretion in response
to prolactin stimulation (Streuli, Bailey, & Bissell, 1991)
(Fig. 1C). Downstream effectors of prolactin, Jak2 and
Stat5, are activated only when MECs adhere to purified
BM but not to Col I (Edwards et al., 1998; Lee & Streuli,
1999). A protein-tyrosine phosphatase is triggered upon
adhesion to Col I, but not purified BM, inhibiting pro-
lactin signalling, probably by direct interaction with Jak2
(Edwards et al., 1998). This phosphatase may be SHP-2
(Akhtar & Streuli, 2006).
Mice genetically lacking functional 1-integrin can
develop alveoli, although with disrupted morphology
and lack of Stat5 nuclear translocation in response to
prolactin stimulation (Li et al., 2005; Naylor et al.,
2005). Two separate studies attributed the structural
abnormalities to alterations in both proliferation and
apoptosis in the modified mammary gland (Faraldo et
al., 1998; Li et al., 2005). How the loss of integrin
1 directly contributes to defective milk secretion is
not entirely understood. It is probably through a con-
trol on prolactin-stimulated signalling, via the integrator
of adhesion signalling, Rac1. Expression of dominant
negative Rac1 leads to disruption of prolactin signalling
in MECs adhering to BM. Moreover, 1−/− MECs had
reduced Rac activity, and constitutively active Rac1,
was sufficient to rescue the 1−/− MEC phenotype and
differentiation (Akhtar & Streuli, 2006). Interestingly,
Cdc42 activity is required for a distinct morphological
process, which is regulated by hormones and not by BM
adhesion. This process is not yet defined but may relate to
the establishment of cell polarity (Etienne-Manneville,
Manneville, Nicholls, Ferenczi, & Hall, 2005; Filipenko
et al., 2005).
Milk secretion and cell polarisation are closely linked
in the mammary gland. The ECM checkpoint enables
MECs to respond to prolactin signaling only when there
is a signal through BM-binding 1-integrin dimers,
thereby coordinating the temporal aspects of differen-
tiation with the spatial requirement for an organised
alveolar architecture. This link is established through
integrin-containing adhesion complexes and Rac1 to
allow prolactin-driven Stat5 nuclear translocation and
the resulting milk synthesis.
8. Modulation of ECM composition and its
relation to integrin signallingThe ability of integrin signalling to dictate the termi-
nal differentiation of MECs has been known for many
years (Medina, Li, Oborn, & Bissell, 1987; Streuli et al.,ochemistry & Cell Biology 39 (2007) 715–726
1991). Perhaps surprisingly, it only emerged later that
the composition of the BM itself may change during
mammary gland development and assist in this pro-
cess (Talhouk, Bissell, & Werb, 1992). Although the
levels of critical BM components such as LM and nido-
gens remain constant during pregnancy and lactation,
the ECM is modified upon induction of involution, and
ligand-bound 1-integrin becomes deactivated (Prince
et al., 2002). This partly occurs through the action of
matrix-degrading metalloproteinases (MMPs) and ser-
ine proteases (Fata, Werb, & Bissell, 2004; Green &
Lund, 2005). In ECM isolated from mammary glands
at various developmental stages, there is evidence for
degradation of both LM and FN during involution
(Schedin et al., 2004). These changes are attributed
to increased MMP activity and may affect 1-integrin
signalling. Interestingly, ECM isolated from involuting
mammary glands (or FN fragments) were sufficient to
induce apoptosis in a normal MEC line, suggesting that
altered ECM composition may actively promote apopto-
sis. Down-regulation of TN during involution (Schedin et
al., 2004) suggests that at least stromal ECM expression
is controlled to avoid the promotion of carcinogenesis
(Scherberich et al., 2005). Specific fragments resulting
from MMP degradation of LM-5 have particularly inter-
esting properties. During involution, the DIII domain
of LM-5 is generated from 3.5 EGF-like repeats in the
LM 2-chain. This domain has the ability to bind to
EGFR and stimulate the MAPK cascade as well as cell
motility and further MMP activity (Schenk et al., 2003).
As stromal cells should also be responsive to this effect
(Sternlicht et al., 2005), DIII and similar LM fragments
may play an unexpected role in directing mammary
gland remodelling during involution.
Lastly, integrin expression itself might be regulated
by BM adhesion. Early evidence suggested an overall
down-regulation of integrin expression, including the
1 and 4 integrins, by purified BM (Delcommenne &
Streuli, 1995). A more specific observation suggests that
nidogen-1 augments the ability of LM-1 to induce mam-
mary epithelial differentiation (Pujuguet et al., 2000).
Taken together, these findings suggest that BM mod-
ulation may contribute by itself to the type of integrin
signalling in each developmental stage of the mammary
gland, thus influencing the checkpoints for MEC fate.
9. Perspective: integration of integrin signallingIntegrin signalling is a critical component of the
temporal–spatial development of the mammary gland.
While studies discussed here demonstrate that this tis-
sue relies on integrins for its function, many questions
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re left unanswered. (1) Which of the precise integrin
imers mediate each of the functions discussed above:
urvival, proliferation, morphogenesis and differentia-
ion? (2) How do the integrin-mediated signals result in
roper terminal differentiation and milk secretion, and
n the process of involution that follows it? (3) Which
recise components of the integrin-containing adhesion
omplex are involved with the different checkpoints?
4) What is the role of integrins on maintaining the
tem cell niche? (5) How does local ECM remodelling
y membrane-bound proteases affect integrin signalling
nd thereby cell fate? (6) What is the influence of inte-
rins on other cell types within the mammary gland,
ncluding stromal cells and myoepithelial cells? (7) To
hat extent to the less-well studied ECM ligands and
eceptors influence integrin signalling?
To achieve this level of understanding more research
nto the molecular mechanisms of signal integration is
equired. For example, anecdotal evidence shows that
AK and ILK are probably involved as scaffold pro-
eins in integrin signaling as much as they are as kinases
Schatzmann et al., 2003) and may serve as a bridge
etween integrins and different receptors such as those
or EGF (Wang et al., 1998). Nonetheless, a long list
f other candidate adaptors includes paxillin and Nck-2,
mong others (Zamir & Geiger, 2001).
The issue of signalling events underlying acinar mor-
hogesis is particularly intriguing. Evidence regarding
he involvement of Rho GTPases begins to shed light on
he processes that may be involved (Akhtar & Streuli,
006). Nonetheless, we are far from a full understand-
ng of how ECM signalling ultimately links to other
ritical cellular elements such as gap and tight junction
ommunication (El-Sabban et al., 2003; Li et al., 2005),
r to desmosomal adhesion (Runswick, O’Hare, Jones,
treuli, & Garrod, 2001).
Although genetic systems, such asCre-Lox gene dele-
ion and the use of shRNA, have now become tractable
or dissecting these questions both in culture and in
ivo, better models will be of key importance. Particular
hallenges will be the development of 3D primary cell
ulture models for studying in vivo-like branching mor-
hogenesis, the stem cell niche, alveolar formation from
ucts, and luminal–myoepithelial–stromal cell interac-
ions, as well as animal models for live cell imaging
nd genetic targeting of both stem cells and stromal
ells.
In this review we have attempted to demonstrate the
nterdependency of tissue architecture and cell fate deci-
ions in mammary gland development and function.
ontinuing efforts in the area of signalling integration
ill undoubtedly be of outmost importance.chemistry & Cell Biology 39 (2007) 715–726 723
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